Discover 1,725 paid clinical trials in Detroit, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,725
Nonopioid Pain Control Regimen After Open Reduction and Internal Fixation of Traumatic Fractures
for
Opioid Use, Fractures, Bone, Trauma
Location: Detroit MI
Sponsor: Henry Ford Health System
Sex: All
Age: 18 - 70+
Code: NCT06113211
Phase 4, Recruiting
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy
for
Malignant Solid Neoplasm
Location: Detroit MI, Clinton Township MI, Grand Rapids MI,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 18+
Code: NCT05642611
Phase 3, Recruiting
Exactech Shoulder Post Market Clinical Follow-up Study
Location: Detroit MI, Royal Oak MI, Ann Arbor MI, London,
Sponsor: Vedanta Biosciences, Inc.
Sex: All
Age: 12+
Code: NCT06237452
Phase 3, Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
for
Relapsed or Refractory Multiple Myeloma
Location: Detroit MI, Ann Arbor MI, Cleveland OH,
Sponsor: Celgene
Sex: All
Age: 18+
Code: NCT05519085
Phase 3, Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Detroit MI, Grosse Pointe Woods MI, Dearborn MI,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT04269902
Phase 3, Recruiting
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
for
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,
Location: Detroit MI, Dearborn MI, Wyandotte MI, Royal Oak MI,
Sponsor: NRG Oncology
Sex: Male
Age: 18+
Code: NCT05946213
Phase 3, Recruiting
A Study to Assess Real-world Patient Characteristics and Clinical Course for Symptomatic Patients With PKP2-ACM